Health Economics and Outcomes Research
Why Health Economics and Outcomes Research (HEOR) Matters
Enhancing the value of healthcare investments, HEOR provides critical evidence on cost-effectiveness and real-world outcomes, enabling informed decisions that maximize patient benefits while navigating budget limitations.
Our offering includes
- Strategic planning, development, and validation of economic evaluation models and health outcome assessments
- Collection of expert opinions and organization of panels (e.g., Delphi method)
- Collection, processing, and modeling of clinical practice data
- Cost-effectiveness, cost-utility, cost-benefit, and cost-minimization models
- Budget impact model
- Disease progression and natural history model
- Adaptation of global models to local context
Contact Us
FAQ
Frequently Asked Questions
Clevidence offers a range of HEOR solutions, including cost-effectiveness modeling, budget impact analysis, and outcomes research. We integrate data from clinical trials, real-world evidence, and healthcare resource utilization, as well as expert methodologies such as the Delphi Panel. This enables us to adapt global models to local contexts, effectively supporting health technology assessments and optimizing resource allocation.
Clevidence demonstrates product value through health economics and outcomes research. We conduct cost-effectiveness analyses and budget impact modeling to help stakeholders understand your product's economic impact. Our services effectively communicate value to decision-makers and promote sustainable clinical and financial outcomes within budget constraints.
Proven Results in Health Economics and Outcomes Research (HEOR)
Strengthening Cost-Effectiveness Analysis with Robust Methodologies
Clevidence worked with a pharmaceutical company to conduct a comprehensive economic evaluation study to support HTA, pricing, and reimbursement for a new drug. By conducting a rigorous cost-effectiveness analysis and budget impact modeling, we gained key insights that demonstrated the economic value and long-term benefits of the product.
This evidence-based strategy facilitates informed decision making by healthcare payers, ensuring appropriate pricing and reimbursement strategies while reinforcing the client’s commitment to delivering value-based healthcare solutions.
